Signal: British biopharma applies for BLA for T-cell cancer therapy – Pharmaceutical Technology
Share this article Acute lymphoblastic leukaemia seen in human blood. Illustration: Science Photo Library/Getty Images. British biopharmaceuticals company Autolus Therapeutics has submitted a Biologics License